BackBridgeBio Oncology Therapeutics Overview

BridgeBio Oncology Therapeutics Goodwill

Track BridgeBio Oncology Therapeutics's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

BridgeBio Oncology Therapeutics Goodwill History

Loading

BridgeBio Oncology Therapeutics vs. peers: Goodwill Comparison

Loading

BridgeBio Oncology Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BridgeBio Oncology Therapeutics (BBOT) FAQ

BridgeBio Oncology Therapeutics posts a goodwill of $0 as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BridgeBio Oncology Therapeutics's goodwill was $0. The latest reading is $0 (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Goodwill is one piece of BridgeBio Oncology Therapeutics's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BBOT's goodwill usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BridgeBio Oncology Therapeutics's other metric pages and overview cover the third.